Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:HCYTD NASDAQ:LGMK OTCMKTS:RSLSD OTCMKTS:USAQ On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHCYTDH-CYTE$2.02-49.5%$2.02$2.02▼$77.00$521K1.12103 shs400 shsLGMKLogicMark$0.00$0.00$0.00▼$7.00$1.90M1.5768.27 million shs1.28 million shsRSLSDReShape Lifesciences$0.00$2.91▼$82.80$1.90M2.031,362 shs6,500 shsUSAQQHSLab$0.15-3.3%$0.19$0.08▼$0.47$1.64M0.451,525 shs3,000 shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHCYTDH-CYTE0.00%0.00%0.00%0.00%0.00%LGMKLogicMark+10.00%+3.12%-23.26%-13.16%-99.92%RSLSDReShape Lifesciences0.00%0.00%0.00%0.00%0.00%USAQQHSLab-3.25%-13.42%-18.10%-22.41%+53.27%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHCYTDH-CYTE$2.02-49.5%$2.02$2.02▼$77.00$521K1.12103 shs400 shsLGMKLogicMark$0.00$0.00$0.00▼$7.00$1.90M1.5768.27 million shs1.28 million shsRSLSDReShape Lifesciences$0.00$2.91▼$82.80$1.90M2.031,362 shs6,500 shsUSAQQHSLab$0.15-3.3%$0.19$0.08▼$0.47$1.64M0.451,525 shs3,000 shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHCYTDH-CYTE0.00%0.00%0.00%0.00%0.00%LGMKLogicMark+10.00%+3.12%-23.26%-13.16%-99.92%RSLSDReShape Lifesciences0.00%0.00%0.00%0.00%0.00%USAQQHSLab-3.25%-13.42%-18.10%-22.41%+53.27%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceHCYTDH-CYTE 0.00N/AN/AN/ALGMKLogicMark 0.00N/AN/AN/ARSLSDReShape Lifesciences 0.00N/AN/AN/AUSAQQHSLab 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookHCYTDH-CYTE$1.61M0.32N/AN/A($31.45) per share-0.06LGMKLogicMark$9.88M0.19N/AN/A$148.65 per share0.00RSLSDReShape Lifesciences$610K0.00N/A0.08$341.84 per share0.00USAQQHSLab$2.13M0.77N/AN/A($0.06) per share-2.58Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateHCYTDH-CYTE-$4.80MN/A0.00∞N/A-450.40%N/A-777.68%N/ALGMKLogicMark-$14.55M-$223.50N/A∞N/A-141.96%-124.91%-92.05%11/11/2025 (Estimated)RSLSDReShape Lifesciences-$81.15MN/A0.00N/AN/A-668.58%-163.22%-52.10%N/AUSAQQHSLab-$260K-$0.04N/A∞N/A-15.33%N/A-21.37%N/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthHCYTDH-CYTEN/AN/AN/AN/AN/ALGMKLogicMarkN/AN/AN/AN/AN/ARSLSDReShape LifesciencesN/AN/AN/AN/AN/AUSAQQHSLabN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioHCYTDH-CYTEN/A0.120.12LGMKLogicMarkN/A3.733.29RSLSDReShape Lifesciences0.051.171.07USAQQHSLabN/A0.160.15Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipHCYTDH-CYTEN/ALGMKLogicMark7.88%RSLSDReShape LifesciencesN/AUSAQQHSLabN/AInsider OwnershipCompanyInsider OwnershipHCYTDH-CYTE5.24%LGMKLogicMark2.17%RSLSDReShape LifesciencesN/AUSAQQHSLab74.19%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableHCYTDH-CYTE8258,000244,000Not OptionableLGMKLogicMark20576.31 million2.65 millionNo DataRSLSDReShape Lifesciences50354,000N/ANot OptionableUSAQQHSLab510.59 million2.73 millionNot OptionableHCYTD, RSLSD, USAQ, and LGMK HeadlinesRecent News About These CompaniesQHSLab (OTCQB: USAQ) Rolls Out Breakthrough Pediatric Screening Tool Linking Allergies and Mental HealthSeptember 2, 2025 | globenewswire.comQHS Healthcare, Powered by QHSLab, Inc. (OTCQB: USAQ), Opens Doors in Miami to Expand Access to Mental Health ServicesJuly 8, 2025 | globenewswire.comQHSLab, Inc. Publishes Peer-Reviewed Studies Validating Digital Tools for Enhancing Patient Outcomes and Healthcare EfficiencyJune 3, 2025 | globenewswire.comQHSLab Enters Advanced Talks for Debt RestructuringMay 16, 2025 | tipranks.comQHSLab, Inc. Signals Strategic Debt Restructuring to Strengthen Balance Sheet and Drive GrowthMay 16, 2025 | globenewswire.comInvesting in Smarter Healthcare: The New Era of AI-Driven MedicineMay 15, 2025 | theglobeandmail.comQHSLab, Inc. Reports 32% Year-Over-Year Revenue Growth and Expanded Gross Margins in First Quarter 2025May 15, 2025 | globenewswire.comUSA Equities Engages Hayden IR for Investor RelationsFebruary 26, 2025 | tipranks.comQHSLab, Inc. Engages Hayden IR to Launch Comprehensive Investor Relations ProgramFebruary 26, 2025 | globenewswire.comQHSLab’s Record Revenue Growth and First Profitable YearFebruary 18, 2025 | tipranks.comQHSLab, Inc. Reports Record Revenue Growth and Positive Net Income in Preliminary Q4 and FY 2024 Financial ResultsFebruary 18, 2025 | globenewswire.comQHSLab and Town Total Compounding Announce Strategic Co-Marketing Partnership to Expand Market Opportunities and Drive Organic GrowthFebruary 11, 2025 | globenewswire.comUSA Equities Highlights 2025 Corporate PresentationJanuary 21, 2025 | tipranks.comUSA Equities to Exhibit at Pri-Med South ConferenceJanuary 16, 2025 | tipranks.comUSA Equities Outlines Growth Strategy Amid ChallengesDecember 17, 2024 | markets.businessinsider.comQHSLab (OTCQB:USAQ) and South Dakota State University Celebrate NSF Invitation to Submit STTR Application for AIR-GUIDDE TechnologyDecember 13, 2024 | globenewswire.comQHSLab, Inc. (OTCQB: USAQ) Marks Major Achievements in Digital Health Innovation, Research Recognition, and Revenue Growth in 2024November 25, 2024 | globenewswire.comQHSLab, Inc. (OTCQB: USAQ) Reports Record Q3 2024 Revenues, Reflecting Accelerated Expansion in Digital Health and Allergy DiagnosticsNovember 14, 2024 | globenewswire.comUS election latest: Harris set to give first speech since Trump's election winNovember 7, 2024 | news.sky.comNThe US city run by Muslim AmericansOctober 26, 2024 | bbc.comBNew MarketBeat Followers Over TimeMedia Sentiment Over TimeHCYTD, RSLSD, USAQ, and LGMK Company DescriptionsH-CYTE OTCMKTS:HCYTD$2.02 -1.98 (-49.50%) As of 07/11/2022H-CYTE, Inc., a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders in the United States. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute a biologic for chronic obstructive pulmonary disease. The company is headquartered in Tampa, Florida.LogicMark NASDAQ:LGMK$0.0033 0.00 (0.00%) As of 12:23 PM EasternLogicMark, Inc. provides personal emergency response systems (PERS), health communications devices, and Internet of Things (IoT) technology that creates a connected care platform in the United States. The company's devices provide people with the ability to receive care at home and age independently and to check, manage, and monitor a loved one's health and safety remotely. It also manufactures and distributes non-monitored and monitored personal emergency response systems, which are offered through the United States Veterans Health Administration (VHA), direct-to-consumers, healthcare durable medical equipment dealers and distributors, monitored security dealers and distributors, and its ecommerce website logicmark.com and Amazon.com. The company was formerly known as Nxt-ID, Inc. and changed its name to LogicMark, Inc. in March 2022. LogicMark, Inc. was founded in 2006 and is based in Louisville, Kentucky.ReShape Lifesciences OTCMKTS:RSLSDReShape Lifesciences Inc., a medical device company, focuses on the design, development, and commercialization of technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. The company's product portfolio includes ReShape vBloc, a therapy that enables patients to feel full and eat less by intermittently blocking hunger signals on the vagus nerve; ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without permanently changing patient anatomy; and Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in October 2017. ReShape Lifesciences Inc. was founded in 2002 and is headquartered in San Clemente, California.QHSLab OTCMKTS:USAQ$0.15 -0.01 (-3.25%) As of 09/15/2025 09:38 AM EasternQHSLab, Inc., a medical device technology and software as a service (SaaS) company, focuses on value-based healthcare, informatics, and algorithmic personalized medicine. It develops digital therapeutics and point of care solutions to support remote patient monitoring, address chronic care, and preventive medicine. The company provides quality health score lab expert system (QHSLab), a cloud-based SaaS system, which provides physicians and healthcare organizations with the ability to capture and store patient information electronically in a secure database; and distributes AllergiEnd, a diagnostic related product and allergen immunotherapy treatments to primary care physicians. Its products are designed to promote prevention, early detection, management, and reversal of chronic diseases. The company was formerly known as USA Equities Corp. and changed its name to QHSLab, Inc. in April 2022. QHSLab, Inc. has a strategic alliance with Medical License Factory, LLC. QHSLab, Inc. was incorporated in 1983 and is based in West Palm Beach, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Lululemon’s Sell-Off Looks Overdone: A Contrarian Case Palantir’s Commercial Growth Story Is Just Getting Started How Bath & Body Works Is a Perfect Example of a Value Stock The Applied Digital Breakout Is Only the Beginning $100 Million Buyback in Upwork Stock Follows a Strong Quarter Why Opendoor Stock Is Soaring—and May Just Be Starting Reddit Hits Record Highs: Why Wall Street Is Taking Notice Royal Caribbean's 33% Dividend Hike Signals Deeper Growth Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
